Market Cap
$5.5B
MMED
MiniMed Group, Inc.
$19.52 ▼ -0.40%
Prev close $19.60Market cap$5.5B
ConsensusStrong Buy
12-mo target$24.92 (+27.6%)
▲ Bullish
Analyst conviction 9/10
High Impact Filing (7/10)12 New Institutional Positions9 Institutional Exits Healthcare & Medical Devices
Snapshot
The big-picture read on MMED right now — valuation, ownership and activity at a glance.
Cap Size
Mid Cap
Analyst Consensus
Strong Buy (89%)
Inst. Holders
50 funds
Inst. Value
$423.5M
Inst. Activity
12 buys / 9 sells
Social Sentiment
67° Warm
SEC Reports
17
Price chart 30d -17.8%
Daily candles (open–high–low–close) with volume. Green = up day, red = down day.
No data for this timeframe.
Vol
Recent activity
The latest filings, insider trades, analyst actions, press and options flow — newest first.
Oct 1, 2026 short_volume
Sep 14, 2026 SEC Short Volume: MMED — 75.9% short (1.3M / 1.7M)
Short: 1,306,901 | Exempt: 0 | TRF Vol: 1,721,083 | Short Ratio: 75.9% | Off-exchange volume (dark p
Medtronic has launched an exchange offer to split off its remaining equity interest in MiniMed, as confirmed by this int
425 — Impact 4/10
Medtronic has launched an exchange offer to split off its remaining equity interest in MiniMed, as confirmed by this int
425 — Impact 4/10
Medtronic has launched an exchange offer to split off its remaining equity interest in MiniMed. This 425 filing describe
425 — Impact 5/10
Jul 31, 2026 Insider
Dallara Que surrendered for taxes 31,350 shares
Chief Executive Officer @ $18.15 ($569.0K)
Jul 31, 2026 Insider
Wills Courtney Nelson surrendered for taxes 1,762 shares
SVP, Gen. Counsel, Corp. Sec. @ $18.15 ($32.0K)
Jul 31, 2026 Insider
Dianaty Ali surrendered for taxes 8,012 shares
EVP Ch. Prod. & Tech Officer @ $18.15 ($145.4K)
Jun 30, 2026 Inst.
BlackRock, Inc. — DOUBLED
1,996,489 shares ($29.8M)
Analyst ratings buy % +4.7%
How Wall Street rates the stock today, and the latest firm-by-firm actions.
89% rate it Buy or better · 18 analysts
Recent analyst actions
| Date | Firm | Action | Rating | Firm rating |
|---|---|---|---|---|
| Sep 24, 2026 | Truist Securities | INITIATE | Buy | 55% |
| Sep 3, 2026 | Morgan Stanley | MAINTAIN | Overweight | 55% |
| Sep 2, 2026 | Citigroup | MAINTAIN | Buy | 55% |
| Sep 2, 2026 | Evercore ISI Group | MAINTAIN | Outperform | 59% |
| Sep 2, 2026 | Wells Fargo | MAINTAIN | Overweight | 54% |
| Sep 2, 2026 | UBS | MAINTAIN | Buy | 55% |
| Sep 2, 2026 | Mizuho | MAINTAIN | Outperform | 52% |
| Sep 2, 2026 | B of A Securities | MAINTAIN | Buy | 54% |
| Sep 1, 2026 | BTIG | MAINTAIN | Buy | 53% |
| Jun 4, 2026 | Wells Fargo | MAINTAIN | Overweight | 54% |
Monthly consensus history
| Period | Str. Buy | Buy | Hold | Sell | Str. Sell | Buy % | Distribution |
|---|---|---|---|---|---|---|---|
| Sep 1, 2026 | 6 | 10 | 2 | 0 | 0 | 89% | |
| Aug 1, 2026 | 6 | 10 | 2 | 0 | 0 | 89% | |
| Jul 1, 2026 | 6 | 10 | 2 | 0 | 0 | 89% | |
| Jun 1, 2026 | 5 | 8 | 2 | 0 | 0 | 87% | |
| May 1, 2026 | 5 | 7 | 2 | 0 | 0 | 86% | |
| Apr 1, 2026 | 4 | 7 | 2 | 0 | 0 | 85% |
Price targets
Where 12 covering analysts think MMED trades over the next 12 months.
$24.92 +27.6% upside Strong Buy
Current$19.52 Low$15.00 Median$26.00 High$29.00 12 analysts
$15.00$29.00
Analyst rating Strong Buy· 1.5/5 as of Oct 2, 2026
Social media sentiment mood +0.0%
Retail-investor mood aggregated across social media. 0° = very bearish, 100° = very bullish.
67°
Warm
BearishNeutralBullish
Recent posts
Reports & filings
AI-scored summaries of recent SEC filings and press releases, with sentiment and impact.
17 SEC filing reports analyzed · 2 bullish, 0 bearish, 3 mixed, 12 neutral · avg impact 4.6/10.
NEUTRAL4254/10
Medtronic has launched an exchange offer to split off its remaining equity interest in MiniMed, as c
Sep 14, 2026
NEUTRAL4254/10
Medtronic has launched an exchange offer to split off its remaining equity interest in MiniMed, as c
Sep 14, 2026
MIXED4255/10
Medtronic has launched an exchange offer to split off its remaining equity interest in MiniMed. This
Sep 14, 2026
NEUTRAL4254/10
Medtronic formally launched an exchange offer to split off its remaining ~89.86% stake in MiniMed, a
Sep 14, 2026
Upcoming & catalyst events
Scheduled dates plus disclosed catalysts — earnings, dividends, enforcement, FDA and clinical-trial events. Colored dot = impact.
Oct 1, 2026
short_volume
Short Volume: MMED — 75.9% short (1.3M / 1.7M)
Short: 1,306,901 | Exempt: 0 | TRF Vol: 1,721,083 | Short Ratio: 75.9% | Off-exchange volume (dark pool + OTC)
Sep 30, 2026
short_volume
Short Volume: MMED — 89.9% short (1.5M / 1.6M)
Short: 1,453,787 | Exempt: 0 | TRF Vol: 1,616,544 | Short Ratio: 89.9% | Off-exchange volume (dark pool + OTC)
Sep 29, 2026
short_volume
Short Volume: MMED — 72.2% short (0.7M / 0.9M)
Short: 671,554 | Exempt: 911 | TRF Vol: 929,512 | Short Ratio: 72.2% | Off-exchange volume (dark pool + OTC)
Sep 28, 2026
other
MiniMed appoints Sheila Denton as General Counsel & Corporate Secretary
NORTHRIDGE, Calif., Sept. 28, 2026 /PRNewswire/ -- MiniMed (Nasdaq: MMED), a global leader in diabetes technology, today announced that Sheila Denton
Sep 28, 2026
short_volume
Short Volume: MMED — 78.7% short (1.1M / 1.4M)
Short: 1,080,963 | Exempt: 0 | TRF Vol: 1,374,287 | Short Ratio: 78.7% | Off-exchange volume (dark pool + OTC)
Earnings estimates
Forecast earnings per share and revenue by period — and whether estimates are rising.
| Period | EPS Est. | Range | Growth | 30d Rev | Up/Dn | Revenue | # |
|---|---|---|---|---|---|---|---|
| Current Q | $0.12 | $0.09–$0.15 | — | -11.3% | 1↑ 2↓ | $0.8B | 8 |
| Next Q | $0.20 | $0.18–$0.22 | 168.8% | +24.6% | 5↑ 0↓ | $0.9B | 8 |
| Current FY | $0.67 | $0.62–$0.74 | 221.1% | +8.7% | 4↑ 2↓ | $3.4B | 8 |
| Next FY | $0.64 | $0.40–$0.77 | -5.5% | -2.7% | 2↑ 2↓ | $3.7B | 8 |
Current-quarter EPS estimate — revision history
| When | EPS estimate | Change vs now |
|---|---|---|
| Current | $0.123 | — |
| 7d ago | $0.122 | +0.001 |
| 30d ago | $0.139 | -0.016 |
| 60d ago | $0.139 | -0.016 |
| 90d ago | $0.147 | -0.024 |
Institutional ownership
Which big funds own MMED (from quarterly 13F filings) and who is adding or trimming.
50 institutional holders with $423.5M total value (28,329,552 shares) as of 2026-Q2. Top holders: MASSACHUSETTS, MILLENNIUM, CITADEL. Net buying activity: 12 institutions added/increased vs 9 reduced.
Top holders — 2026-Q2
| Fund | Shares | Value | % Tracked | Last move |
|---|---|---|---|---|
| MASSACHUSETTS FINANCIAL SERVICES CO /MA/ | 8,334,738 | $124.6M | 29.4% | NEW |
| MILLENNIUM MANAGEMENT LLC | 3,060,615 | $45.8M | 10.8% | ADD +87.5% |
| CITADEL ADVISORS LLC | 2,865,703 | $42.8M | 10.1% | — |
| BlackRock, Inc. | 1,996,489 | $29.8M | 7.0% | DOUBLED +7527.5% |
| NORGES BANK | 1,961,002 | $29.3M | 6.9% | NEW |
| ExodusPoint Capital Management, LP | 1,437,067 | $21.5M | 5.1% | DOUBLED +251.1% |
| FMR LLC | 1,080,689 | $16.2M | 3.8% | NEW |
| GEODE CAPITAL MANAGEMENT, LLC | 956,024 | $14.3M | 3.4% | DOUBLED +288.7% |
| Boston Partners | 902,359 | $13.5M | 3.2% | NEW |
| Nuveen, LLC | 539,313 | $8.1M | 1.9% | — |
Recent position changes
| Fund | Action | Prev | Current | Change | Value |
|---|---|---|---|---|---|
| BlackRock, Inc. | DOUBLED | 26,175 | 1,996,489 | +7527.5% | $29.8M |
| NORGES BANK | NEW | — | 1,961,002 | — | $29.3M |
| ExodusPoint Capital Management, LP | DOUBLED | 409,248 | 1,437,067 | +251.1% | $21.5M |
| GEODE CAPITAL MANAGEMENT, LLC | DOUBLED | 245,931 | 956,024 | +288.7% | $14.3M |
| UBS Group AG | ADD | 311,349 | 413,416 | +32.8% | $6.2M |
| HEALTHCARE OF ONTARIO PENSION PLAN TRUST FUND | TRIM | 750,000 | 375,000 | -50.0% | $5.6M |
| FIRST TRUST ADVISORS LP | DOUBLED | 99,149 | 366,268 | +269.4% | $5.5M |
| TUDOR INVESTMENT CORP ET AL | DOUBLED | 15,900 | 258,215 | +1524.0% | $3.9M |
| BANK OF AMERICA CORP /DE/ | DOUBLED | 50,063 | 238,819 | +377.0% | $3.6M |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | DOUBLED | 24,554 | 76,710 | +212.4% | $1.1M |
Insider activity
Buying and selling by company executives and directors (SEC Form 4).
8 insiders, 50 transactions. Net $0.00 — $0.00 bought, $0.00 sold.
| Date | Insider | Title | Type | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Jul 31, 2026 | Dallara Que | Chief Executive Officer | TAX W/H | 31,350 | $18.15 | $569.0K |
| Jul 31, 2026 | Wills Courtney Nelson | SVP, Gen. Counsel, Corp. Sec. | TAX W/H | 1,762 | $18.15 | $32.0K |
| Jul 31, 2026 | Dianaty Ali | EVP Ch. Prod. & Tech Officer | TAX W/H | 8,012 | $18.15 | $145.4K |
| Jul 28, 2026 | Chandrasena Gillian | SVP, Chief HR Officer | TAX W/H | 2,099 | $17.67 | $37.1K |
| Jul 28, 2026 | Spooner Chad | EVP, Chief Financial Officer | TAX W/H | 23,301 | $17.67 | $411.7K |
| Jul 1, 2026 | Dallara Que | Chief Executive Officer | AWARD | 297,618 | — | — |
| Jul 1, 2026 | Gyurci John | VP, Chief Accounting Officer | AWARD | 24,244 | — | — |
| Jul 1, 2026 | Chandrasena Gillian | SVP, Chief HR Officer | AWARD | 14,705 | — | — |
| Jul 1, 2026 | Wills Courtney Nelson | SVP, Gen. Counsel, Corp. Sec. | AWARD | 60,730 | — | — |
| Jul 1, 2026 | Spooner Chad | EVP, Chief Financial Officer | AWARD | 22,057 | — | — |
Short interest & halts
FINRA semi-monthly short positions, Reg SHO threshold status, and recent trading halts for MMED.
Shares short
13,594,922
Settlement Sep 15, 2026
Change vs prior
+68.7%
Semi-monthly cycle
Days to cover
4.8
At avg daily volume
Of shares outstanding
≈4.8%
Estimate — not % of float
All MMED filing & press-release reports (17)
- 425 reportSep 14, 2026
- 425 reportSep 14, 2026
- 425 reportSep 14, 2026
- 425 reportSep 14, 2026
- 425 reportSep 14, 2026
- 425 reportSep 14, 2026
- S-4, 425 reportSep 14, 2026
- 8-K reportSep 1, 2026
- 3 reportJul 6, 2026
- 8-K reportJun 29, 2026
- INST-CLUSTER reportJun 11, 2026
- 8-K reportJun 3, 2026
- 8-K reportMay 18, 2026
- 8-K reportApr 27, 2026
- 424B4 reportMar 6, 2026
- EFFECT reportMar 6, 2026
- S-1/A reportFeb 27, 2026